Your search returned 3 results.

Results
	1.	The histone deacetylase inhibitor valproic acid potently augments gemtuzumab ozogamicin-induced apoptosis in acute myeloid leukemic cells. [electronic resource] by ten Cate, B Samplonius, D F Bijma, T de Leij, L F M H Helfrich, W Bremer, E Producer: 20070925 In: Leukemia vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability. [electronic resource] by ten Cate, B Bremer, E de Bruyn, M Bijma, T Samplonius, D Schwemmlein, M Huls, G Fey, G Helfrich, W Producer: 20090921 In: Leukemia vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery. [electronic resource] by Reeßing, F Stuart, M C A Samplonius, D F Dierckx, R A J O Feringa, B L Helfrich, W Szymanski, W Producer: 20191009 In: Chemical communications (Cambridge, England) vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search